Design and methods of the MAINTAIN study: A randomized controlled clinical trial of micronutrient and antioxidant supplementation in untreated HIV infection

Contemporary Clinical Trials

Volumn 31, Issue 6, 2010, Pages 604-611

  Singhal, Neera ^a   Fergusson, Dean ^a   Huff, Harold ^b   Mills, Edward J ^c   la Porte, Charles ^a   Walmsley, Sharon ^d   Cameron, D William ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

^b CANADIAN COLLEGE OF NATUROPATHIC MEDICINE   (Canada)

^c UNIVERSITY OF OTTAWA   (Canada)

^d UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

Antioxidants; Antiretroviral therapy; HIV; Immunity; Micronutrients; Randomized clinical trial

Indexed keywords

ANTIOXIDANT; ANTIRETROVIRUS AGENT; CENTRUM; K PAX ULTRA; MINERAL; MULTIVITAMIN; TRACE ELEMENT; UNCLASSIFIED DRUG;

ARTICLE; CANADA; CD4+ T LYMPHOCYTE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNITY; LYMPHOCYTE COUNT; METHODOLOGY; MULTICENTER STUDY; PATIENT COMPLIANCE; PATIENT SELECTION; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; STUDY DESIGN;

ADULT; ANTIOXIDANTS; CANADA; CD4 LYMPHOCYTE COUNT; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; HIV INFECTIONS; HUMANS; MEDICATION ADHERENCE; MICRONUTRIENTS; PROSPECTIVE STUDIES; QUALITY OF LIFE; RESEARCH DESIGN; SAMPLE SIZE; SELECTION BIAS;

EID: 77957956538     PISSN: 15517144     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cct.2010.08.003     Document Type: Article

References (40)

1. Sappey C., Leclercq P., Coudray C., Faure P., Micoud M., Favier A. Vitamin, trace element and peroxide status in HIV seropositive patients: asymptomatic patients present a severe beta-carotene deficiency. Clin Chim Acta 1994, 230(1):35-42.
2. Allard J.P., Aghdassi E., Chau J., Salit I., Walmsley S. Oxidative stress and plasma antioxidant micronutrients in humans with HIV infection. Am J Clin Nutr 1998, 67(1):143-147.
3. Schwarz K.B. Oxidative stress during viral infection: a review. Free Radic Biol Med 1996, 21(5):641-649.
4. Treitinger A., Spada C., Verdi J.C., Miranda A.F., Oliveira O.V., Silveira M.V., et al. Decreased antioxidant defence in individuals infected by the human immunodeficiency virus. Eur J Clin Invest 2000, 30(5):454-459.
5. Baum M., Cassetti L., Bonvehi P., Shor-Posner G., Lu Y., Sauberlich H. Inadequate dietary intake and altered nutrition status in early HIV-1 infection. Nutrition 1994, 10(1):16-20.
6. Skurnick J.H., Bogden J.D., Baker H., Kemp F.W., Sheffet A., Quattrone G., et al. Micronutrient profiles in HIV-1-infected heterosexual adults. J Acquir Immune Defic Syndr Hum Retrovirol 1996, 12(1):75-83.
7. Irlam J.H., Visser M.E., Rollins N., Siegfried N. Micronutrient supplementation in children and adults with HIV infection. Cochrane Database Syst Rev 2005, 4:CD003650.
8. Tang A.M., Lanzillotti J., Hendricks K., Gerrior J., Ghosh M., Woods M., et al. Micronutrients: current issues for HIV care providers. AIDS 2005, 19(9):847-861.
9. Singhal N., Austin J. A clinical review of micronutrients in HIV infection. J Int Assoc Physicians AIDS Care (Chic Ill) 2002, 1(2):63-75.
10. Austin J., Singhal N., Voigt R., Smaill F., Gill M.J., Walmsley S., et al. A community randomized controlled clinical trial of mixed carotenoids and micronutrient supplementation of patients with acquired immunodeficiency syndrome. Eur J Clin Nutr 2006, 60(11):1266-1276.
11. Kaiser J.D., Campa A.M., Ondercin J.P., Leoung G.S., Pless R.F., Baum M.K. Micronutrient supplementation increases CD4 count in HIV-infected individuals on highly active antiretroviral therapy: a prospective, double-blinded, placebo-controlled trial. J Acquir Immune Defic Syndr 2006, 42(5):523-528.
12. Alexander M., Newmark H., Miller R.G. Oral beta-carotene can increase the number of OKT4+ cells in human blood. Immunol Lett 1985, 9(4):221-224.
13. Baeten J.M., McClelland R.S., Wener M.H., Bankson D.D., Lavreys L., Mandaliya K., et al. Relationship between markers of HIV-1 disease progression and serum beta-carotene concentrations in Kenyan women. Int J STD AIDS 2007, 18(3):202-206.
14. Rall L.C., Meydani S.N. Vitamin B6 and immune competence. Nutr Rev 1993, 51(8):217-225.
15. Tang A.M., Graham N.M., Chandra R.K., Saah A.J. Low serum vitamin B-12 concentrations are associated with faster human immunodeficiency virus type 1 (HIV-1) disease progression. J Nutr 1997, 127(2):345-351.
16. Cifone M.G., Alesse E., Di Marzio L., Ruggeri B., Zazzeroni F., Moretti S., et al. Effect of L-carnitine treatment in vivo on apoptosis and ceramide generation in peripheral blood lymphocytes from AIDS patients. Proc Assoc Am Physicians 1997, 109(2):146-153.
17. Hart A.M., Wilson A.D., Montovani C., Smith C., Johnson M., Terenghi G., et al. Acetyl-l-carnitine: a pathogenesis based treatment for HIV-associated antiretroviral toxic neuropathy. AIDS 2004, 18(11):1549-1560.
18. Moretti S., Famularo G., Marcellini S., Boschini A., Santini G., Trinchieri V., et al. L-carnitine reduces lymphocyte apoptosis and oxidant stress in HIV-1-infected subjects treated with zidovudine and didanosine. Antioxid Redox Signal 2002, 4(3):391-403.
19. Breitkreutz R., Pittack N., Nebe C.T., Schuster D., Brust J., Beichert M., et al. Improvement of immune functions in HIV infection by sulfur supplementation: two randomized trials. J Mol Med 2000, 78(1):55-62.
20. Droge W., Breitkreutz R. N-acetyl-cysteine in the therapy of HIV-positive patients. Curr Opin Clin Nutr Metab Care 1999, 2(6):493-498.
21. Cavallini L., Alexandre A. Oral N-acetyl-cysteome increases the production of anti HIV chemokines in peripheral blood mononuclear cells. Life Sci 2000, 67(2):147-154.
22. Cossarizza A., Mussini C., Mongiardo N., Borghi V., Sabbatini A., De Rienzo B., et al. Mitochondria alterations and dramatic tendency to undergo apoptosis in peripheral blood lymphocytes during acute HIV syndrome. AIDS 1997, 11(1):19-26.
23. Cossarizza A., Franceschi C., Monti D., Salvioli S., Bellesia E., Rivabene R., et al. Protective effect of N-acetylcysteine in tumor necrosis factor-alpha-induced apoptosis in U937 cells: the role of mitochondria. Exp Cell Res 1995, 220(1):232-240.
24. Baur A., Harrer T., Peukert M., Jahn G., Kalden J.R., Fleckenstein B. Alpha-lipoic acid is an effective inhibitor of human immuno-deficiency virus (HIV-1) replication. Klin Wochenschr 1991, 69(15):722-724.
25. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep 1992, 41(RR-17):1-19. CDC.
26. Hammer S.M., Eron J.J., Reiss P., Schooley R.T., Thompson M.A., Walmsley S., et al. Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel. Jama 2008, 300(5):555-570.
27. Balfour L., Tasca G.A., Kowal J., Corace K., Cooper C.L., Angel J.B., et al. Development and validation of the HIV Medication Readiness Scale. Assessment 2007, 14(4):408-416.
28. HIV diagnosis at CD4 count above 500 cells/mm3 and progression to below 350 cells/mm3 without antiretroviral therapy. J Acquir Immune Defic Syndr 2007, 46(3):275-278.
29. Clinical outcomes from OPTIMA: A randomized controlled trial of antiretroviral treatment interruption of intensification interruption or intensification in advance multi-drug resistant HIV infection. International Aids Conference 2008, August 3-8; Mexico City; 2008 August 3-8, Team OPTIMA.
30. www.hc-sc.gc.ca/dhp-mps/prodpharma/applic-demande/guide-ld/ich/efficac/e6_e.html., accessed April 27, 2010.
31. http://laws.justice.gc.ca/en/F-27/C.R.C.-c.870/index.html., accessed April 27, 2010.
32. www.pre.ethics.gc.ca., accessed April 27, 2010.
33. Bjelakovic G., Nikolova D., Gluud L.L., Simonetti R.G., Gluud C. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. Jama 2007, 297(8):842-857.
34. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. N Engl J Med 1994, 330(15):1029-1035.
35. Tang A.M., Graham N.M., Saah A.J. Effects of micronutrient intake on survival in human immunodeficiency virus type 1 infection. Am J Epidemiol 1996, 143(12):1244-1256.
36. Semba R.D., Ricketts E.P., Mehta S., Netski D., Thomas D., Kirk G., et al. Effect of Micronutrients and Iron Supplementation on Hemoglobin, Iron Status, and Plasma Hepatitis C and HIV RNA Levels in Female Injection Drug Users: A Controlled Clinical Trial. J Acquir Immune Defic Syndr 2007, 45(3):298-303.
37. Doherty C.P. Host-pathogen interactions: the role of iron. J Nutr 2007, 137(5):1341-1344.
38. Lange J., Gazzard B., Diaz R. Reduced CD4+ T cell decline and immune activation by NR100157: a specific multi-targeted nutritional intervention in HIV-1 positive adults not on antiretroviral therapy (BITE). Abstract H-1230b. 49th ICAAC (Interscience Conference on Antimicrobial Agents and Chemothetherapy) 2009; San Francisco 2009.
39. http://clinicaltrials.gov/ct2/show/NCT00860977., accessed April 27, 2010.
40. http://www.aidsinfo.nih.gov/Guidelines/., accessed April 27, 2010.